Topical CBD for Musculoskeletal Pain

Phase 3

• Conditions: Pain

• Registration Number: NCT05411913
• Lead Sponsor: Apothyx, Co.

Brief Summary

Various OTC and CBD containing topicals are evaluated in a double blind survey. Each sample has a QR code that is to be scanned before applying. The QR code links to a survey form with application instructions and collects participant information and feedback.

Detailed Description

Not available

Study Timeline

• Status Verified: 2022-06
• Study First Submitted: 2022-06-02
• Study First Submitted QC: 2022-06-06
• Last Update Submitted: 2022-06-06
• Study First Posted: 2022-06-09
• Last Update Posted: 2022-06-09
• Study Start: 2022-07-01
• Primary Completion: 2022-10-31
• Study Completion: 2022-11-25

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• has Pain

Exclusion Criteria

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Pain Before/After Application	5 min post intervention	McGill Pain Questionnaire

Secondary Outcome Measures

Name	Time	Method
Efficiency	5 min post intervention	Time and Duration of Pain Relief